Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicorette Freshmint gum vs Nicorette Microtab in smokers with tooth staining
2005-001040-23Phase 4Completed
- Sponsor
- Pfizer
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of Nicoderm C-Q Gum in nicotine dependence (2 arms), sponsored by Pfizer. Primary endpoint: Mean change in modified extrinsic tooth stain score (total) from baseline at 6 weeks. Started May 2005; status: completed.
02
Drugs
Nicoderm C-Q Gum
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2005-001040-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001040-23.